2013-03-26 14:15:09 UTC

List of DDW® Sessions and Research on the Gut Microbiome Now Available

March 28, 2013

The new AGA Center for Gut Microbiome Research and Education has announced the list of invited speaker sessions and oral research abstracts on the gut microbiome to be presented at Digestive Disease Week® 2013.

The AGA Center for Gut Microbiome Research and Education, the newly created virtual “home” for all AGA activities related to the gut microbiome, has released the list of invited speaker sessions and oral research abstracts on the gut microbiome to be presented at Digestive Disease Week® 2013. Sessions will discuss the myriad of possibilities that the gut microbiome offers to GI basic and translational researchers, clinicians, and patients.

DDW sessions will highlight new research on microbiome, specifically reporting on its impact on IBD, cirrhosis, celiac disease, colon cancer and more.

Featured sessions include:

  • The Intestinal Microbiome and the Gutbrain Axis
  • Pediatric Gastroenterology: Microbiota, Probiotics and Prebiotics
  • Microbiome in Inflammatory Bowel Disease
  • Fecal Transplantation for C. difficile Disease: Is It Ready for Prime Time?
  • Colon Cancer Risk: Impact of Diet, the Microbiota and the Metabolome
  • Novel Therapies for Infectious Diarrhea

Also, don’t miss the AGA Basic Science Plenary on Sunday, May 19, from 2 to 4 p.m. featuring additional microbiome research.

Consult the official DDW program for complete information about these and other presentations relevant to the microbiome.

More on Celiac Disease

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

APPs: Enhance your delivery of patient care

March 28, 2018

AGA's popular course for advanced practice providers will be held this summer in Chicago.

HLA-DQ–Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption

March 1, 2018

An HLA-DQ–gluten tetramer based assay that detects gluten-specific T cells accurately identifies patients with and without celiac disease, regardless of whether the individuals are on a gluten-free diet.